Huntington Disease Clinical Trial
Verified date | September 2017 |
Source | Institut National de la Santé Et de la Recherche Médicale, France |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this project investigators will evaluate the benefits of contemporary dance training using
a comprehensive test battery combining standard neuropsychological batteries, psychological
questionnaires on emotion, empathy and quality of life, structural magnet-resonance
tomography (MRI), as well as psychophysical tests on movement recognition and agency, the
sense of being in control of one's own movement.
For 10 years now two experienced dancerâchoreographers lead dance workshops for people with
Huntington's Disease (HD) and their family and caregivers in Paris. This project will
evaluate objectively the effects these workshops have, by assessing a new group of 18
patients and their partners and caregivers before and after 8 month of weekly dance training.
People with HD are troubled by involuntary movements, of which they are however not
accurately aware, but moreover they become impaired at recognising instrumental actions in
others. It is well known that observing somebody else's action and executing the same action
rest on a common neural network. This might mean that improving one's own action execution
can improve the observation and understanding of others' actions in turn. Here, investigators
will investigate both the impact the movement impairments caused by HD might have on patients
themselves as well as on their partners and caregivers, as a consequence of the fact that own
and other action representations are shared. After 8 months of contemporary dance training,
both groups will be tested again, in order to establish if both action execution (self) and
perception (in others) have improved.
Other recent psychophysics and brain imaging experiments have demonstrated how the sense of
agency is composed from external cues (for example sound) of the consequences of movements,
and from internal sensorimotor information that result from the action plan. Importantly, in
HD the latter input might be impaired, but this has never been systematically tested. Making
use of a psychophysics paradigm disentangling the two cues to agency investigators first
monitor the sense of their own movement in HD, and further assess the changes in agency and
in the role of these cues to agency after eight months of contemporary dance practice.
Finally investigators will monitor the structural brain changes accompanying this progress,
comparing the brain before and after regular dance practice and correlating action
recognition psychophysics measures of agency with these changes.
In sum, this project has a double impact. Firstly it will scientifically evaluate the impact
of dance on the normal but especially the brain affected by a neurodegenerative disease that
causes movement impairments, and establish its effect on behaviour and wellbeing. Secondly it
will evaluate in patient partners and caregivers how they represent the patients' as well as
their own movements and how this changes with dance practice.
Status | Completed |
Enrollment | 53 |
Est. completion date | July 8, 2016 |
Est. primary completion date | July 28, 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Huntington patient - Patients with Huntington's disease (documented by a genetic test.) - Ability and intention to follow the dance workshop of the association Micadanse once a week for 8 months (Total Functional Capacity score (TFC) > 10). - Have an assisting person who also lends him/herself to the protocol. - Showing no indications against to the achievement of MRI. Assisting person: - No history of neurological or psychiatric disorders. - Showing no indications against to the achievement of MRI. Exclusion Criteria: - Have already taken dance lessons. - Neurological or psychiatric history. - Inability to achieve MRI - History of significant head injury |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Institut National de la Santé Et de la Recherche Médicale, France |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Detection score | The subject performs movements imposed which are recorded by sensors in the form of bright spots. It shows the participant of "bright spots" of himself or of another subject of the same sex and must indicate whether of himself or another person. The number of correct answers is calculated and subtracted from the numbers of false positives. |
Day 1 | |
Primary | Detection score | The subject performs movements imposed which are recorded by sensors in the form of bright spots. It shows the participant of "bright spots" of himself or of another subject of the same sex and must indicate whether of himself or another person. The number of correct answers is calculated and subtracted from the numbers of false positives. The number of correct answers is calculated and subtracted from the numbers of false positives. |
9th month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Not yet recruiting |
NCT04429230 -
Non-invasive Brain Stimulation in Huntington's Disease
|
N/A | |
Recruiting |
NCT05032196 -
Study of WVE-003 in Patients With Huntington's Disease
|
Phase 1/Phase 2 | |
Recruiting |
NCT03599076 -
Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease Huntington's Disease
|
||
Terminated |
NCT04617860 -
Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT05748288 -
Development of the Virtual Unified Huntington's Disease Rating Scale
|
||
Not yet recruiting |
NCT05360082 -
Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
|
||
Not yet recruiting |
NCT04370470 -
Development of Assessments for Later Stage HD
|
||
Recruiting |
NCT01834053 -
Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.
|
Phase 1/Phase 2 | |
Completed |
NCT01458470 -
A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease
|
Phase 2 | |
Completed |
NCT01357681 -
Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)
|
Phase 2 | |
Completed |
NCT00980694 -
Bioavailability of Ubiquinol in Huntington Disease
|
Phase 1 | |
Completed |
NCT00146211 -
TREND-HD - A Trial of Ethyl-EPA (Miraxionâ˘) in Treating Mild to Moderate Huntington's Disease
|
Phase 3 | |
Recruiting |
NCT01412125 -
Study of Biomarkers That Predict the Evolution of Huntington's Disease
|
N/A | |
Completed |
NCT00075140 -
Family Health After Predictive Huntington Disease (HD) Testing
|
Phase 3 | |
Recruiting |
NCT04818060 -
Preparing for Prevention of Huntington's Disease (PREVENT-HD)
|
||
Active, not recruiting |
NCT04698551 -
NIPD on cffDNA for Triplet Repeat Diseases
|
||
Not yet recruiting |
NCT04301726 -
Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated With HD
|
Phase 1 | |
Completed |
NCT03421327 -
Genetic Risk: Whether, When, and How to Tell Adolescents
|
||
Recruiting |
NCT03296176 -
Metabolomic Study in Huntington's Disease (METABO-HD)
|
N/A |